Difference between revisions of "CT Volumetry Biomarker Ctte"

Revision as of 15:52, 26 January 2023

Co-chairs: Rudresh Jarecha, MBBS, DNB, DMRE; Ehsan Samei, PhD and TBD

RSNA Staff Support: Julie Lisiecki

Meetings

Tcons are held periodically. Contact RSNA Staff for details.

Recent Call Summaries:

CT Volumetry BC Call Summaries Archive

Profile Development

Streamlined Profile (also on Profile page)

CT Tumor Volume Change for Advanced Disease (CTV-AD) 2022-07-21 Streamlined Profile

32 pages including Conformance Checklists

Status - Balloting Streamlined Profile

CT Tumor Volume Change Profile - Streamlined Draft 2022.03.03
CT Tumor Volume Change Profile - Streamlined Draft 2021.12.09

The Technically Confirmed Profile is on the Profiles page.

Stage 4 Planning

Draft Stage 4 Plan - Google Doc

Past and Future

Archived Versions of Profile-related documents.
Considerations for Future Editions of CTV-AD

Groundwork Projects

These projects investigate (and resolve) scientific questions underlying QIBA Profile work.

VolCT - Group 1A - Analyze Bias/Variance where Ground Truth is Known Deterministically
VolCT - Group 1B - Focus on Volume Change Analysis of Pulmonary Nodules in Diagnostic Settings
VolCT - Group 1C - Model Sources of Variability from a Systems Engineering Analysis
VolCT - Group 3A - Characterize variability due to algorithms (using phantoms / clinical data)
VolCT - Group 3B - Characterize clinical utility/efficacy with respect to clinical endpoints
VolCT - Colorado Group - Quantifying variability in measurement of pulmonary nodule

NIBIB-2 Proposal for CT Volumetry16-APR-2012

Reference Materials

2012

Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
- ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.
"Why QIBA?" - Specifics associated with CT device and software manufacturers.

2011

Dr Petrick's 2011 SPIE Presentation Materials
“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Talk
“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Paper
Compliance Documents: QIBA Approach to Compliance-- Andrew J. Buckler, MS, Program Director, QIBA 08.15.11

2010

Quantification in Imaging-Dr Dirk Colditz August 23, 2010
Project plan .jpg version as of 11-8-10

Reference Articles

Are we ready? A time for measurement of physiological parameters of the lung using multidetector row CT scans. Hatabu H. Acad Radiol. 2009 Mar; 16(3):249. Academic Radiology
Radiology 2007 - Coronary Calcium Scoring - This paper by Dr. McCollough et al is may be seen to be analaogous to our work in that it addresses similar issues (e.g. achieving "standard" noise levels). It could be thought of as an early draft of a Calcium Scoring profile, including both groundwork and equipment specifications.
Helical multidetector row quantitative computed tomography (QCT) precision. Bligh M, Bidaut L, White RA, Murphy WA Jr, Stevens DM, Cody DD. Acad Radiol. 2009 Feb; 16(2):150-9. Academic Radiology
Comparison of the accuracy of CT volume calculated by circumscription to prolate ellipsoid volume (bidimensional measurement multiplied by coronal long axis). Rkein AM, Harrigal C, Friedman AC, Persky D, Krupinski E. Acad Radiol. 2009 Feb; 16(2):181-6. Academic Radiology

Archive - Initial Target Selection and Roadmap

QIBA Funded Projects

Round 1

Round 2

Round 3

Project (F) Second 3A Statistical and Image Processing Analysis (Elucid Bioimaging Inc.)

Round 4

Project (Q) Phantoms Methodology and Reference Image Set for Volumetric Characterization and Compliance (Duke University)

Project (S) Phantoms for CT Volumetry of Hepatic and Nodal Metastasis (CUMC)

Round 5

Project (C) Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization (Duke University)

Round 6

Project (S) Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology (Duke University)

@@ Line 1: / Line 1: @@
 {{TOCright}}
-:Co-chairs: Rudresh Jarecha, MBBS, DNB, DMRE, Ehsan Samei, PhD and Jenifer Siegelman, MD, MPH;
+:Co-chairs: Rudresh Jarecha, MBBS, DNB, DMRE; Ehsan Samei, PhD and TBD
-:Secretary: Julie Lisiecki
+:RSNA Staff Support: Julie Lisiecki
 * [http://tinyurl.com/QIBA-CT-Vol-Roster Roster]
+* [https://docs.google.com/spreadsheets/d/1qbBHaJNTAqHnAcmCTHsNfDph7hMyJ3NoUjYSdilVw8w/edit#gid=267283460 Attendance & Voting Privileges]
 ==Meetings==
-* Tcons are held roughly Weekly. Contact the secretary for details.
+* Tcons are held periodically. Contact RSNA Staff for details.
 '''Recent Call Summaries:'''
+*[[Media:02 00 2023 QIBA CT Volumetry BC Call-FINAL.pdf|02.00.2023 QIBA CT Volumetry BC Call Summary]]
+*[[Media:11 01 2022 QIBA CT Volumetry BC Call-FINAL.pdf|11.01.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:10 10 2022 QIBA CT Volumetry BC Call-FINAL.pdf|10.10.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:08 17 2022 QIBA CT Volumetry BC Call-FINAL.pdf|08.17.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:06 29 2022 QIBA CT Volumetry BC Call-FINAL.pdf|06.29.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:05 26 2022 QIBA CT Volumetry BC Call-FINAL.pdf|05.26.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:04 20 2022 QIBA CT Volumetry BC Call-FINAL.pdf|04.20.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:03 15 2022 QIBA CT Volumetry BC Call-FINAL.pdf|03.15.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:02 15 2022 QIBA CT Volumetry BC Call-FINAL.pdf|02.15.2022 QIBA CT Volumetry BC Call Summary]]
-*[[Media:05 03 2018 QIBA CT Volumetry BC Call-FINAL.pdf|05.03.2018 QIBA CT Volumetry Call Summary]]
-*[[Media:02 12 2018 QIBA CT Volumetry BC Call-FINAL.pdf|02.12.2018 QIBA CT Volumetry Call Summary]]
-*[[Media:01 29 2018 QIBA CT Volumetry BC Call-FINAL.pdf|01.29.2018 QIBA CT Volumetry Call Summary]]
+'''''[[CT Volumetry BC Call Summaries Archive]]'''''
-'''''''[[CT Volumetry BC Call Summaries Archive]]'''''
 ==Profile Development==
+'''Streamlined Profile (also on Profile page)'''
+* [[Media:QIBACTVol_TumorVolumeChange(2022)-20220721.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2022-07-21 Streamlined Profile]]
+:* 32 pages including Conformance Checklists
-===Advanced Disease/Tumor Volume Change Profile===
-'''Status - Technical Confirmation in Ballot'''
+'''Status - Balloting Streamlined Profile'''
+*[[Media:QIBA Profile Streamlining Proposal - CTVol TumorVolumeChange-20220303.docx| CT Tumor Volume Change Profile - Streamlined]] Draft 2022.03.03
+*[[Media:QIBA Profile Streamlining Proposal - CTVol TumorVolumeChange-20211209.docx| CT Tumor Volume Change Profile - Streamlined]] Draft 2021.12.09
-*[[Media:QIBA_CTVol_TumorVolumeChangeProfile_DraftTechConfirmed-20180511-changetracked.docx | CT Tumor Volume Change Profile - Change tracked]] ''BALLOT DRAFT 2018.05.11''
+The Technically Confirmed Profile is on the [[Profiles]] page.
-** This document shows all changes between the published Consensus Profile and the Ballot for Technically Confirmed.
+'''Stage 4 Planning'''
+:* [https://docs.google.com/document/d/1Wcmkzp8N_2lLL-FCykNPwgsn1BJOs7Z9A1ZyTIkuGCo/edit?usp=sharing Draft Stage 4 Plan - Google Doc]
-Past and Future
+'''Past and Future'''
 :* [[Archived Versions#Advanced_disease|Archived Versions]] of Profile-related documents.
 :* [[CTV-AD Considerations for Future Editions|Considerations for Future Editions of CTV-AD]]
@@ Line 47: / Line 58: @@
 *Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
 **[[Media:ATCC is an independent private nonprofit 7-3-12.pdf|ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.]]
-*[[Media:Why_QIBA_CT_specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
+*[[Media:Why QIBA CT specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
 '''2011'''
@@ Line 57: / Line 68: @@
 '''2010'''
 *[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
-*[[Media: Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
+*[[Media:Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
 ==Reference Articles==
@@ Line 79: / Line 90: @@
 *[[CoreLab Partners, Inc., Round-2]]
 *[[David Geffen School of Medicine at UCLA, Department of Radiology,Round-2]]
+'''Round 3'''
+*[[Media:Second 3A Statistical and Image Processing Analysis.pdf| Project (F) Second 3A Statistical and Image Processing Analysis (Elucid Bioimaging Inc.)]]
+'''Round 4'''
+*[[Media:Methodology and Reference Image Set for Volumetric Characterization and Compliance.pdf| Project (Q) Phantoms Methodology and Reference Image Set for Volumetric Characterization and Compliance (Duke University)]]
+*[[Media:Phantoms for CT Volumetry of Hepatic and Nodal Metastasis.pdf| Project (S) Phantoms for CT Volumetry of Hepatic and Nodal Metastasis (CUMC)]]
+'''Round 5'''
+*[[Media:Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization.pdf| Project (C) Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization (Duke University)]]
+'''Round 6'''
+*[[Media:Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology.pdf| Project (S) Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology (Duke University)]]